The price of a box of desutumumab is around $1,060, and may vary slightly from region to region. Dixumab is a RANKL inhibitor, this drug can currently be used for the treatment of advanced inoperable giant cell tumor of bone, can also be used for the prevention and treatment of cancer-induced bone metastatic lesions, or for the treatment of multiple myeloma-induced bone-related adverse events, but also for the treatment of postmenopausal women’s osteoporosis and so on. Dixumab is usually used once every 4 weeks, choose the subcutaneous injection of the drug, the drug is easy to cause hypocalcemia, osteonecrosis of the jaw, allergies and other reactions, during the use of the drug can be used with the drug as well as more sun exposure to replenish calcium. It is recommended to use the drug under the guidance of a professional doctor, not self-medication, regular review during the use of medication, if there is any discomfort in time to consult a doctor.